Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Duloxetine for SSRI-Induced Sexual Dysfunction
NCT00398632Phase 4Terminated
- Sponsor
- Stanford University
- Start
- Nov 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in major depressive disorder (MDD), persistent depressive disorder (PDD), sponsored by Stanford University. Started Nov 2006; status: terminated.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00398632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398632.